Introduction
The acute respiratory distress syndrome (ARDS) is an important cause of acute respiratory failure that is often associated with multiple organ failure. ARDS continues to be both prevalent and very morbid, with an estimated ageadjusted incidence of 86.2 per 100,000 patient years, and reported in-hospital mortality of nearly 40%. 1 Many risk factors for ARDS have been reported. For example, infection, alcohol abuse, cigarette smoke exposure and race have been reported to be associated with ARDS development. 2 Besides, genetic susceptibility may also be an important determinant of the incidence of ARDS. 3 Angiotensin-converting enzyme (ACE) is a key enzyme that converts angiotensin to angiotensin II. Casey et al. found that patients with ARDS and sepsis had markedly decreased serum ACE levels. 4 Fourrier et al. also suggested that serum ACE levels decreased and were closely correlated with the severity of lung injury. 5 However, Idell and coworkers found that broncho-alveolar lavage ACE was elevated in some ARDS patients, especially those with infectious causes of lung injury. 6 Recently, a study indicated that the administration of captopril prevented rats from OA-induced severe lungs injury, with a significantly lower lung injury score, less albumin content and infiltrated cells in the alveoli, decreased wet/dry weight ratio of the lung tissues and improved lung function (PaO2 per fraction of inspired oxygen). 7 The ACE gene is located on chromosome 17q35 and consists of 26 exons spread over approximately 24 kb. The intron 16 of the ACE gene contains a restriction fragment length polymorphism consisting of the presence (insertion, I) or absence (deletion, D) of a 287-bp alu repeat sequence. 8 Several previous studies have studied the association between ACE I/D polymorphism and ARDS risk. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Two meta-analyses regarding this association have been reported. 19, 20 Hu et al. suggested that ACE I/D polymorphism may be associated with ARDS among Caucasians. 19 However, Matsuda and colleagues indicated that ACE I/D polymorphism was not associated with susceptibility to ARDS in Caucasians. 20 Therefore, the results were inconclusive and contradictory. Moreover, new studies have been reported since then. 17, 18 We thus performed a metaanalysis to investigate the association between ACE I/D polymorphism and ARDS risk.
Methods

Publication search
All relevant studies were searched using PubMed and EMBASE. (The last retrieval date was 10 October 2014, using the search terms: 'acute respiratory distress syndrome or ARDS or ALI or acute lung injury' and 'angiotensinconverting enzyme or ACE'.) All found studies were retrieved and only published studies with full-text articles were included. When there was more than publication with duplicate samples, only the newest study was used in this research.
Study selection
The inclusion criteria were as follows: (1) the research was a case-control study or a cohort study; (2) the study investigated the association between ACE I/D polymorphism and ARDS risk; (3) the ACE I/D genotypes of individual groups were provided. The exclusion criteria were as follows: (1) no usable data reported; (2) animal studies; (3) reviews or abstracts.
Data extraction
Two authors extracted the data independently. These data included: the first author, year, country, ethnicity, age group, gender and sample size. Authors were contacted by Email if further study details were needed. Any disagreement was resolved by consensus.
Statistical analysis
Statistical analysis was conducted using Stata software 11.0 (StataCorp, College Station, Texas, USA). A Hardy-Weinberg equilibrium (HWE) test in a healthy control group was conducted using χ 2 test. Odds ratio (OR) with a 95% confidence interval (CI) was presented for dichotomous data, and significant level was 0.05. The Q-statistic and the I 2 -statistic were used to measure statistical heterogeneity, and the significant level was 0.10. Effect model selection was on the basis of a heterogeneity test. A fixed-effects model was selected when there was no significant heterogeneity, otherwise a random-effects mode was usedl. Subgroup analyses based on race and age were performed. Cumulative meta-analysis and sensitivity analysis were also conducted. To explore the source of the heterogeneity, Galbraith plots were used. Publication bias was test using Begg's test and a funnel plot (significant level was 0.05).
Results
Eligible studies
The characteristics of the included studies were listed in Table 1 . Ten studies with 5218 subjects were included in this meta-analysis. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Three studies reported two or three cohorts, thus 14 case-control studies were treated as independent studies. Five studies were conducted with Asian patients and nine studies were performed with Caucasian patients. Two studies used pediatric patients and the rest of the studies used adults. The results of HWE were also shown in Table 1 .
Quantitative data synthesis
Previous studies showed that the ACE DD genotype was associated with higher ACE production that ACE ID or II genotype. 21 Therefore, we investigated the association between ACE I/D polymorphism and ARDS risk in the recessive model (DD vs DI+II). We found that ACE I/D polymorphism significantly associated with an increased ARDS risk (OR=1.57; 95% CI 1.30-1.89; P<0.00001; Figure 1 ). In the subgroup analysis by race, Caucasians with ACE I/D polymorphism showed increased ARDS risk Table 2 . Cumulative meta-analysis was conducted by the assortment of studies by publication time (Figure 2) . To determine the stableness of the result, we performed the sensitivity analysis by omitting one study at a time. We found that single study did not impact the pooled OR, indicating that the results of our research were statistically robust (Figure 3 ). There was significant heterogeneity (I 2 =72%, P<0.0001) in the recessive genetic model. The Galbraith plot was used to find the source of the heterogeneity. As shown in Figure  4 , three studies were outliers. After excluding these studies, the between-study heterogeneity effectively decreased and there was no obvious heterogeneity among the 11 remaining studies (I 2 =0%, P=0.69). Besides, the result was marginally significant (OR=1.27, 95% CI 1.00-1.61, P=0.05).
Egger's test and Begg's funnel plot were conducted to assess the publication bias. The shape of funnel plot was symmetry ( Figure 5 ). Egger's test did not detect obvious publication bias (P=0.913). 
Discussion
This meta-analysis of 14 case-control studies evaluated the association between ACE I/D polymorphism and ARDS risk. We found that ACE I/D polymorphism might be a risk factor for developing ARDS. This result suggested that ACE DD genotype carriers might have increased ARDS risk compared to ID or II carriers. In the race subgroup analysis, Caucasians but not Asians with ACE I/D polymorphism showed increased ARDS risk. There were only three studies with Asians. More studies with Asian populations are still needed to validate our results. In addition, we also found that ACE I/D polymorphism was associated with ARDS risk in adults. Since there were only two studies with pediatric patients, more studies with these populations are needed to validate the result of this meta-analysis. To the best of our knowledge, this was the most comprehensive meta-analysis of the association between ACE I/D polymorphism and ARDS risk. Rigat et al. found that plasma ACE levels of subjects who carried the DD genotype were twofold compared to levels found in patients carrying the II genetic polymorphism (ID subjects having intermediate levels). 22 Previous studies suggested that the activation of the renin-angiotensin system in the lung may be related to the development of ARDS, probably because of decreased alveolar epithelial cell survival, 5 changes in vascular permeability 23 or fibroblast proliferation. 24 ACE levels were elevated in BAL and administration of ACEI protected the rats from severe lungs injury. 6, 7 Thus, ACE I/D polymorphism might be associated with increased ARDS risk.
This meta-analysis had several limitations. Firstly, the sample size for this polymorphism was relatively small. Thus, the statistical power of genetic effects identified might be hampered. However, results from cumulative meta-analysis and sensitivity analysis suggested that our results are reliable and robust. Secondly, the number of included studies was moderate. Thus, the results of this meta-analysis might be influenced by the factors like publication bias, etc. However, no publication bias was found in our study. Third, our study did not address gene-gene and gene-environment interactions.
Conclusion
In conclusion, this meta-analysis indicated that ACE I/D polymorphism may be associated with the risk of ARDS. Well-designed studies with larger sample size and more ethnic groups should be considered to further confirm this association.
